Hello everyone , as we all know the market action discounts everything :) We can tell from all the signs and indicators that the ENTX stock is moving in a strong uptrend , all the data that we gathered and saw on the chart looks makes the market is in a great place to buy .
I am seeing 2 ways the market is possibly moving in the next few weeks :
1_The market is...
I bought this one several days ago and there is still a huge amount of upside. If it can get through the $4.30 and $4.80 resistance a double is a real deal. They have had solid revenues the last 2 Q and are based in Isreal. They have partnered in a project with Amgen and have been around I think since 2003. The Timeframes tell the story and the flow of the chart...
Trend breakout analysis for ENTX:
Much more upside than downside from here as consolidation persists.
News from final 6months interim coming up in Q2 could bring good Volume back to this stock.
Shorts have been taking this stock hostage for a while now.. Longs will have a nice come back to newer highs if results are significant enough.
If you have any comments,...
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, an oral parathyroid hormone product candidate, which is in Phase 2 clinical trials for the treatment of hypoparathyroidism;...
Hey everyone! I'm new to trading and learning to spot patterns. This looks like a cup and handle to me. From what I understand, cup and handle patterns are supposed to be easy money. Feedback would be much appreciated! Thanks!
Bullish Flag (107%)
Pros:
Volume during post formation
Descending volume during flag formation
Golden cross in blue
PPS above 50MA and 200MA
RS above 0 and ascending
R/R ratio above 5
ATR ascending
200MA ascending, barely
250RSI above 50 and ascending
Cons:
Gap may be filled back to 1.60$
Target:
PT = 10.87$
Help how ever you can to keep this alive.
Thank you...
Entera Bio Ltd Announces Positive Topline EB613 Phase 2 Biomarker Data
‒ Trial Met Primary Endpoint of Significant Increase in P1NP Based on Final Analysis of 3 Month Data
‒ Final Analysis of 6-Month Data, Including Change in Bone Mineral Density, Expected in Q2:21
‒ The trial’s primary endpoint was met - the complete 3-month results from the trial showed a...
This has news AH that clinical trials have good results. 70% success rate. Went above its previous support of $3.80 from March of 2019 and stayed above that all day. If it bounces of that support in the morning dip, would be an excellent point to buy.
Second resistance level is around $5. If it breaks that before open then that's a clear breakout.
